Literature DB >> 1457356

Oestrogen receptor protein and mRNA in adenocarcinoma of the uterine cervix.

S M Ismail1, G A Thomas, F A Ghandour, H G Davies, R Attanoos, E D Williams.   

Abstract

We have investigated the oestrogen receptor (ER) status of 20 cervical adenocarcinomas by immunocytochemistry for ER protein and non-isotopic in situ hybridisation for ER mRNA. Both methods, which are applicable to paraffin sections, were developed and validated in breast carcinomas with known ER content. Six cervical adenocarcinomas contained immunocytochemically demonstrable ER protein; all contained ER mRNA, but staining was less intense in poorly differentiated areas of four tumours. This disparity between protein and mRNA detection needs further investigation as does the possibility that oestrogens may play a role in the pathogenesis of cervical adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457356      PMCID: PMC1978005          DOI: 10.1038/bjc.1992.425

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.

Authors:  S Green; P Walter; V Kumar; A Krust; J M Bornert; P Argos; P Chambon
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

2.  Increased incidence of adenocarcinoma of the cervix in young women in the United States.

Authors:  S M Schwartz; N S Weiss
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

3.  Estrogen receptor distribution in the normal and pathologically changed human cervix uteri: an immunohistochemical study with use of monoclonal anti-ER antibody.

Authors:  J Kupryjańczyk; P Möller
Journal:  Int J Gynecol Pathol       Date:  1988       Impact factor: 2.762

4.  Expression of estrogen receptors, progesterone receptors, and an estrogen receptor-associated protein in the human cervix during the menstrual cycle and menopause.

Authors:  A Cano; V Serra; J Rivera; R Monmeneu; C Marzo
Journal:  Fertil Steril       Date:  1990-12       Impact factor: 7.329

5.  Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva.

Authors:  L C Ford; J S Berek; L D Lagasse; N F Hacker; Y L Heins; R J DeLange
Journal:  Gynecol Oncol       Date:  1983-02       Impact factor: 5.482

6.  Analysis of human p53 proteins and mRNA levels in normal and transformed cells.

Authors:  G Matlashewski; L Banks; D Pim; L Crawford
Journal:  Eur J Biochem       Date:  1986-02-03

7.  Detection of estrogen receptor in paraffin-embedded sections of breast carcinoma by immunohistochemistry and in situ hybridization.

Authors:  D M Graham; L Jin; R V Lloyd
Journal:  Am J Surg Pathol       Date:  1991-05       Impact factor: 6.394

8.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

9.  Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County.

Authors:  R K Peters; A Chao; T M Mack; D Thomas; L Bernstein; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

10.  Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe.

Authors:  M Farquharson; R Harvie; A M McNicol
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.